Ghrelin also acts via GH-independent pathways to suppress the pro-inflammatory and catabolic milieu that drives cachexia as it stimulates the release of the anti-inflammatory cytokine IL-10 while reducing levels of TNF-α, IL-1β, and IL-6. The gene discussed is IL1B; the disease is Cachexia.